10-Q Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 Q2 2023

Filing Information

Form Type	10-Q
Accession Number	`0001213900-23-064519`
Period End Date	20230630
Filing Date	20230808
Fiscal Year	2023
Fiscal Period	Q2
XBRL Instance	f10q0623_relmadatherap_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 54 Income Statement 58 Cash Flow Statement 54 Stockholders Equity 28

Balance Sheet 54 line items

Line Item	Tag	Value	Unit	Period
Convertible preferred stock par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Convertible preferred stock par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Convertible preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.50M	shares	Point-in-time
Convertible preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.50M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$14.47M	USD	Point-in-time
Convertible preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.40M	USD	Point-in-time
Convertible preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Convertible preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$142.93M	USD	Point-in-time
Convertible preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$104.06M	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$512.43K	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	-	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$4.04M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$3.47M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$122.00M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.10M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$152.87M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.10M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.10M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$34.88K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$34.59K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.10M	shares	Point-in-time
Total assets	`Assets`	$122.04M	USD	Point-in-time
Total assets	`Assets`	$152.91M	USD	Point-in-time
Commitments and Contingencies (See Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (See Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$4.85M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$5.26M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$5.85M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$7.21M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$10.70M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.47M	USD	Point-in-time
Class A convertible preferred stock, $0.001 par value, 3,500,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Class A convertible preferred stock, $0.001 par value, 3,500,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, 150,000,000 shares authorized, 30,099,203 shares issued and outstanding	`CommonStockValue`	$30.10K	USD	Point-in-time
Common stock, $0.001 par value, 150,000,000 shares authorized, 30,099,203 shares issued and outstanding	`CommonStockValue`	$30.10K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$625.04M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$602.52M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-462.11M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-513.74M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$208.26M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$210.40M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$111.34M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$196.85M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$140.44M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$125.47M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$152.91M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$122.04M	USD	Point-in-time

Income Statement 58 line items

Line Item	Tag	Value	Unit	Period
Loss per common share diluted	`EarningsPerShareDiluted`	$-2.73	USD	2 Qtrs
Loss per common share diluted	`EarningsPerShareDiluted`	$-1.33	USD	1 Quarter
Loss per common share diluted	`EarningsPerShareDiluted`	$-1.72	USD	2 Qtrs
Loss per common share diluted	`EarningsPerShareDiluted`	$-0.84	USD	1 Quarter
Weighted average number of common shares outstanding Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	29.17M	shares	2 Qtrs
Weighted average number of common shares outstanding Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	29.94M	shares	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$13.74M	USD	1 Quarter
Weighted average number of common shares outstanding Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	30.10M	shares	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$55.93M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$29.60M	USD	2 Qtrs
Weighted average number of common shares outstanding Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	30.10M	shares	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$30.91M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$14.60M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$12.29M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$24.58M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$27.88M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$45.51M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$83.81M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$26.03M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$54.18M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-45.51M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-26.03M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-83.81M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-54.18M	USD	2 Qtrs
Gain on settlement of fees	`GainLossRelatedToLitigationSettlement`	-	USD	1 Quarter
Gain on settlement of fees	`GainLossRelatedToLitigationSettlement`	$6.35M	USD	1 Quarter
Gain on settlement of fees	`GainLossRelatedToLitigationSettlement`	-	USD	2 Qtrs
Gain on settlement of fees	`GainLossRelatedToLitigationSettlement`	$6.35M	USD	2 Qtrs
Interest/investment income, net	`InterestIncomeExpenseNet`	$387.33K	USD	1 Quarter
Interest/investment income, net	`InterestIncomeExpenseNet`	$1.36M	USD	1 Quarter
Interest/investment income, net	`InterestIncomeExpenseNet`	$717.28K	USD	2 Qtrs
Interest/investment income, net	`InterestIncomeExpenseNet`	$2.57M	USD	2 Qtrs
Realized (loss) gain on short-term investments	`RealizedInvestmentGainsLosses`	-	USD	1 Quarter
Realized (loss) gain on short-term investments	`RealizedInvestmentGainsLosses`	$24.50K	USD	1 Quarter
Realized (loss) gain on short-term investments	`RealizedInvestmentGainsLosses`	$9.48K	USD	2 Qtrs
Realized (loss) gain on short-term investments	`RealizedInvestmentGainsLosses`	$-666.71K	USD	2 Qtrs
Unrealized (loss) gain on short-term investments	`UnrealizedGainLossOnInvestments`	$-1.19M	USD	1 Quarter
Unrealized (loss) gain on short-term investments	`UnrealizedGainLossOnInvestments`	$-2.95M	USD	2 Qtrs
Unrealized (loss) gain on short-term investments	`UnrealizedGainLossOnInvestments`	$-639.63K	USD	1 Quarter
Unrealized (loss) gain on short-term investments	`UnrealizedGainLossOnInvestments`	$651.48K	USD	2 Qtrs
Total other income	`NonoperatingIncomeExpense`	$2.56M	USD	2 Qtrs
Total other income	`NonoperatingIncomeExpense`	$723.77K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$5.58M	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$4.13M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-25.30M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-51.62M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-39.75M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-79.68M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-26.32M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-39.93M	USD	1 Quarter
Loss per common share basic (in Dollars per share)	`EarningsPerShareBasic`	$-2.73	USD	2 Qtrs
Loss per common share basic (in Dollars per share)	`EarningsPerShareBasic`	$-1.72	USD	2 Qtrs
Loss per common share basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.84	USD	1 Quarter
Loss per common share basic (in Dollars per share)	`EarningsPerShareBasic`	$-1.33	USD	1 Quarter
Weighted average number of common shares outstanding basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	30.10M	shares	1 Quarter
Weighted average number of common shares outstanding basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	29.94M	shares	1 Quarter
Weighted average number of common shares outstanding basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	29.17M	shares	2 Qtrs
Weighted average number of common shares outstanding basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	30.10M	shares	2 Qtrs

Cash Flow Statement 54 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-25.30M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-51.62M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-39.75M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-79.68M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-26.32M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-39.93M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$22.52M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$24.23M	USD	2 Qtrs
Gain on settlement of fees	`GainsLossesOnExtinguishmentOfDebt`	$6.35M	USD	2 Qtrs
Gain on settlement of fees	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Realized loss (gain) on short-term investments	`IncomeLossFromEquityMethodInvestments`	$-666.71K	USD	2 Qtrs
Realized loss (gain) on short-term investments	`IncomeLossFromEquityMethodInvestments`	$9.48K	USD	2 Qtrs
Unrealized (gain) loss on short-term investments	`UnrealizedsLossgainOnShorttermInvestments`	$-2.95M	USD	2 Qtrs
Unrealized (gain) loss on short-term investments	`UnrealizedsLossgainOnShorttermInvestments`	$651.48K	USD	2 Qtrs
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	$-44.14K	USD	2 Qtrs
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	-	USD	2 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$-512.43K	USD	2 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$256.19K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpense`	$-7.81M	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpense`	$-560.93K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-408.32K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.70M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-1.36M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$7.51M	USD	2 Qtrs
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-29.78M	USD	2 Qtrs
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-41.06M	USD	2 Qtrs
Purchase of short-term investments	`PaymentsToAcquireInvestments`	$33.41M	USD	2 Qtrs
Purchase of short-term investments	`PaymentsToAcquireInvestments`	$45.58M	USD	2 Qtrs
Sale of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$84.43M	USD	2 Qtrs
Sale of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$23.24M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-10.17M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$38.85M	USD	2 Qtrs
Proceeds from issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$42.73M	USD	2 Qtrs
Proceeds from issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Proceeds from options exercised for common stock	`ProceedsFromStockOptionsExercised`	$417.54K	USD	2 Qtrs
Proceeds from options exercised for common stock	`ProceedsFromStockOptionsExercised`	-	USD	2 Qtrs
Proceeds from warrants exercised for common stock	`ProceedsFromWarrantExercises`	-	USD	2 Qtrs
Proceeds from warrants exercised for common stock	`ProceedsFromWarrantExercises`	$895.36K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$44.04M	USD	2 Qtrs
Net increase/(decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-7.18M	USD	2 Qtrs
Net increase/(decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$9.07M	USD	2 Qtrs
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$14.47M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$37.26M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.40M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$44.44M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$14.47M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$37.26M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.40M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$44.44M	USD	Point-in-time
Interest	`InterestPaid`	-	USD	2 Qtrs
Interest	`InterestPaid`	-	USD	2 Qtrs
Income Tax	`IncomeTaxesPaidNet`	-	USD	2 Qtrs
Income Tax	`IncomeTaxesPaidNet`	-	USD	2 Qtrs

Stockholders Equity 28 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$208.26M	USD	Point-in-time
Balance	`StockholdersEquity`	$210.40M	USD	Point-in-time
Balance	`StockholdersEquity`	$111.34M	USD	Point-in-time
Balance	`StockholdersEquity`	$196.85M	USD	Point-in-time
Balance	`StockholdersEquity`	$140.44M	USD	Point-in-time
Balance	`StockholdersEquity`	$125.47M	USD	Point-in-time
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$11.17M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$11.35M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$11.93M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$12.30M	USD	1 Quarter
ATM offering, net of offering costs	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$13.15M	USD	1 Quarter
ATM offering, net	`StockIssuedDuringPeriodValueOther`	$29.58M	USD	1 Quarter
Warrant exercised for cash	`StockIssuedDuringPeriodValueNewIssues`	$300.01K	USD	1 Quarter
Warrant exercised for cash	`StockIssuedDuringPeriodValueNewIssues`	$595.35K	USD	1 Quarter
Options exercised for cash	`StockIssuedDuringPeriodValueStockOptionsExercised`	$64.80K	USD	1 Quarter
Options exercised for cash	`StockIssuedDuringPeriodValueStockOptionsExercised`	$352.74K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-25.30M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-51.62M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-39.75M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-79.68M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-26.32M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-39.93M	USD	1 Quarter
Balance	`StockholdersEquity`	$208.26M	USD	Point-in-time
Balance	`StockholdersEquity`	$210.40M	USD	Point-in-time
Balance	`StockholdersEquity`	$111.34M	USD	Point-in-time
Balance	`StockholdersEquity`	$196.85M	USD	Point-in-time
Balance	`StockholdersEquity`	$140.44M	USD	Point-in-time
Balance	`StockholdersEquity`	$125.47M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.